Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic immunomodulation.

G M Galbraith1

  • 1Department of Microbiology and Immunology, Medical University of South Carolina, Charleston.

Dermatologic Clinics
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Several immunomodulatory agents show promise in clinical applications. Interleukin-2, interferons, and colony-stimulating factors are effective for various diseases, while monoclonal antibodies and inosiplex offer potential for cancer, immune deficiencies, and transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health-care workers and latex allergy.

Archives of environmental health·2000
Same author

Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis.

Journal of clinical periodontology·1999
Same author

Contribution of interleukin 1beta and KM loci to alopecia areata.

Human heredity·1999
Same author

Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis.

Journal of clinical periodontology·1998
Same author

Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype.

Journal of periodontology·1998
Same author

Cytokine production by oral and peripheral blood neutrophils in adult periodontitis.

Journal of periodontology·1997
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Immunology
  • Clinical Therapeutics
  • Biotechnology

Background:

  • Cytokines are key regulators of the immune system with significant clinical potential.
  • Various immunomodulatory agents, including cytokines, antibodies, and synthetic compounds, are being explored for therapeutic applications.

Purpose of the Study:

  • To review the clinical efficacy and potential applications of several immunomodulatory agents.
  • To highlight the role of interleukin-2, interferons, colony-stimulating factors, monoclonal antibodies, and inosiplex in treating diverse medical conditions.

Main Methods:

  • Review of existing clinical data and research on immunomodulatory therapies.
  • Analysis of the therapeutic applications of specific cytokines, antibodies, and synthetic compounds.

Related Experiment Videos

Main Results:

  • Interleukin-2 combined with lymphokine-activated killer cells shows potential for antitumor therapy.
  • Interferons are effective against viral diseases and hematologic malignancies.
  • Colony-stimulating factors show promise for bone marrow dysfunction.
  • Monoclonal antibodies are effective in allograft rejection and graft-versus-host disease.
  • Inosiplex may enhance immune function in patients with immune deficiencies like AIDS.

Conclusions:

  • Immunomodulatory agents represent a diverse and promising class of therapeutics.
  • Targeted application of these agents offers significant potential for treating cancer, viral infections, immune deficiencies, and transplantation complications.